Trial intelligence / Profile preview

Fibore for Radiation Dermatitis in Breast Cancer

NCT04239560Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Feb 2019
Primary completion
Sep 2019
Modality
Dietary Supplement
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in radiation dermatitis comparing Boron-based Gel with Placebo (2 arms). Primary endpoint: Radiation Therapy Oncology Group (RTOG) criteria for Radiation Dermatitis at Day 25. Started Feb 2019; status: completed.

02

Drugs

sodium pentaborate pentahydrate
03

Conditions

radiation dermatitis

Beyond the preview

Go deeper on NCT04239560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04239560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call